Literature DB >> 9865459

Neutrophilia of infection/inflammation: are we really dealing with "inflamed" leukocytes?

Y Sasson1, D Zeltser, O Rogowski, M Kassirer, N Maharshak, A Nissenkorn, E Leibovitz, P Halperin, D Sharvit, P Sorkine, N Arber, S Berliner.   

Abstract

We adopted whole blood flow cytometry and direct labeling of the CD11b/CD18 and CD62L antigens to study the relationship between their expression and leukocytosis in patients with infection/inflammation, acute stress and healthy volunteers. Mean +/- S.D. channel fluorescence intensity of CD11b/CD18 antigen on peripheral blood polymorphonuclears did not differ between patients with infection/ inflammation (173+/-78) and controls (167+/-72), but was significantly (p = 0.04) reduced in stress (135+/-60). No correlation was found between CD11b/CD18 antigen level and either polymorphonuclears absolute number or serum C-reactive protein. A significant negative correlation was noted between CD62L antigen expression on polymorphonuclears and their absolute number. We assume that cells with increased CD11b/CD18 surface concentrations are retained in the capillaries and that part of the leukocytes in the peripheral blood are stressed leukocytes with reduced CD11b/CD18. Thus, leukocytes detected in peripheral blood are not necessarily the most "inflamed" ones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865459

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  2 in total

1.  Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids.

Authors:  P Ballabh; M Simm; J Kumari; A N Krauss; A Jain; C Califano; M L Lesser; S Cunningham-Rundles
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

2.  Recurrent respiratory tract infections in children - analysis of immunological examinations.

Authors:  Agata Raniszewska; Elżbieta Górska; Iwona Kotuła; Anna Stelmaszczyk-Emmel; Katarzyna Popko; Olga Ciepiela
Journal:  Cent Eur J Immunol       Date:  2015-08-03       Impact factor: 2.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.